Philip M. Brown

4.3k total citations · 2 hit papers
105 papers, 2.5k citations indexed

About

Philip M. Brown is a scholar working on Surgery, Molecular Biology and Dermatology. According to data from OpenAlex, Philip M. Brown has authored 105 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Molecular Biology and 13 papers in Dermatology. Recurrent topics in Philip M. Brown's work include Dermatology and Skin Diseases (13 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and DNA and Nucleic Acid Chemistry (8 papers). Philip M. Brown is often cited by papers focused on Dermatology and Skin Diseases (13 papers), Psoriasis: Treatment and Pathogenesis (9 papers) and DNA and Nucleic Acid Chemistry (8 papers). Philip M. Brown collaborates with scholars based in United States, United Kingdom and Canada. Philip M. Brown's co-authors include Arthur G. Pratt, John D. Isaacs, Keith R. Fox, Marcie J. Hursting, Anita Abu‐Daya, Kimme L Hyrich, Marian P. LaMonte, P.H. Sönksen, Peter H. Sönksen and Stephen Smith and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Philip M. Brown

100 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers

2016 302 citations Philip M. Brown, Arthur G. Pratt et al. profile →
Therapeutic advances in rheumatoid arthritis

2024 130 citations Philip M. Brown, Arthur G. Pratt et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip M. Brown United States	28	557	462	351	307	277	105	2.5k
Damien Gruson Belgium	26	652 1.2×	405 0.9×	445 1.3×	206 0.7×	201 0.7×	182	2.9k
Κassem Sharif Israel	27	486 0.9×	282 0.6×	262 0.7×	614 2.0×	484 1.7×	101	3.7k
Yolanda Jiménez Spain	41	836 1.5×	683 1.5×	740 2.1×	452 1.5×	705 2.5×	118	4.8k
Lijuan Wang China	29	649 1.2×	529 1.1×	291 0.8×	322 1.0×	105 0.4×	173	3.3k
Takahisa Kawaguchi Japan	28	1000 1.8×	497 1.1×	395 1.1×	304 1.0×	269 1.0×	132	3.7k
Wen‐Pin Chen Taiwan	38	883 1.6×	503 1.1×	343 1.0×	109 0.4×	147 0.5×	186	3.8k
Shaye Kivity Israel	32	793 1.4×	381 0.8×	443 1.3×	800 2.6×	820 3.0×	107	4.0k
Ju‐Young Kim South Korea	32	1.1k 2.0×	399 0.9×	798 2.3×	318 1.0×	207 0.7×	170	4.2k
Catherine Creuzot‐Garcher France	38	689 1.2×	381 0.8×	186 0.5×	221 0.7×	112 0.4×	254	5.0k
Ross McManus Ireland	34	914 1.6×	674 1.5×	511 1.5×	1.1k 3.6×	257 0.9×	102	4.2k

Countries citing papers authored by Philip M. Brown

Since Specialization

Citations

This map shows the geographic impact of Philip M. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip M. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip M. Brown more than expected).

Fields of papers citing papers by Philip M. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip M. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip M. Brown. The network helps show where Philip M. Brown may publish in the future.

Co-authorship network of co-authors of Philip M. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Philip M. Brown. A scholar is included among the top collaborators of Philip M. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip M. Brown. Philip M. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Ashley W., et al.. (2025). Next generation crop protection: A systematic review of trends in modelling approaches for disease prediction. Computers and Electronics in Agriculture. 234. 110245–110245. 2 indexed citations

Simpson, Eric L., Jonathan I. Silverberg, Robert Bissonnette, et al.. (2024). 671 - Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis. British Journal of Dermatology. 191(Supplement_2). 1 indexed citations

Sigurdsson, Hilmar P., Lisa Alcock, Michael Firbank, et al.. (2024). Developing a novel dual-injection FDG-PET imaging methodology to study the functional neuroanatomy of gait. NeuroImage. 288. 120531–120531.

Brown, Philip M., Arthur G. Pratt, & Kimme L Hyrich. (2024). Therapeutic advances in rheumatoid arthritis. BMJ. 384. e070856–e070856. 130 indexed citations breakdown →

Ardle, Ríona Mc, Philip M. Brown, Heather L. Hunter, et al.. (2023). Feasibility and usability of a digital health technology system to monitor mobility and assess medication adherence in mild-to-moderate Parkinson's disease. Frontiers in Neurology. 14. 1111260–1111260. 22 indexed citations

Gold, Linda Stein, et al.. (2023). 41626 Tapinarof Cream 1% Once Daily for Plaque Psoriasis in Two Pivotal Phase 3 Trials: Minimal Systemic Exposure is Consistent With Adverse Event Profile. Journal of the American Academy of Dermatology. 89(3). AB229–AB229. 2 indexed citations

Silverberg, Jonathan I., Mark Boguniewicz, Francisco J. Quintana, et al.. (2023). Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review. Journal of Allergy and Clinical Immunology. 154(1). 1–10. 44 indexed citations

Maunder, Daniel, Philip M. Brown, Dennis Lendrem, et al.. (2023). Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacy. Lara D. Veeken. 63(8). 2259–2267. 8 indexed citations

Paller, Amy S., et al.. (2023). 301 Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial. British Journal of Dermatology. 188(Supplement_2). 1 indexed citations

10.

Silverberg, Jonathan I., Mark Boguniewicz, David S. Rubenstein, Anna M. Tallman, & Philip M. Brown. (2023). TAPINAROF CREAM IMPROVED ITCH IN TWO PHASE 3 TRIALS OF MODERATE TO SEVERE ATOPIC DERMATITIS. Annals of Allergy Asthma & Immunology. 131(5). S90–S90. 3 indexed citations

11.

Bagel, Jerry, Linda Stein Gold, J.Q. Del Rosso, et al.. (2023). Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial. Journal of the American Academy of Dermatology. 89(5). 936–944. 12 indexed citations

12.

Anderson, Amy E., Arthur G. Pratt, Ben Hargreaves, et al.. (2015). IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis. Annals of the Rheumatic Diseases. 75(2). 466–473. 55 indexed citations

13.

Northcote, Maria T, et al.. (2011). Benchmark yourself: Self-reflecting about online teaching. 2011(1). 904–908. 8 indexed citations

14.

LaMonte, Marian P., Philip M. Brown, & Marcie J. Hursting. (2005). Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor. Expert Review of Cardiovascular Therapy. 3(1). 31–41. 17 indexed citations

15.

LaMonte, Marian P., Philip M. Brown, & Marcie J. Hursting. (2004). Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy. Critical Care Medicine. 32(4). 976–980. 70 indexed citations

16.

Brown, Philip M., et al.. (2000). Faculty Hiring Practices in Social Work Education: A National Survey. 1(2). 2 indexed citations

17.

Brown, Philip M., et al.. (1997). Cross-Cultural Considerations in Family Preservation Practice. Journal of Family Social Work. 2(2). 141–158. 3 indexed citations

18.

Wynne, Hilary, Philip M. Brown, & Peter H. Sönksen. (1985). Acceptability and effectiveness of self‐administered intramuscular insulin in juvenile‐onset diabetes. Practical Diabetes International. 2(4). 32–33. 3 indexed citations

19.

Cockram, Clive S., et al.. (1985). Single and double voided urine testing: A comparison with blood glucose monitoring in insulin‐dependent diabetics. Practical Diabetes International. 2(3). 38–41. 1 indexed citations

20.

Smith, Stephen, Stephen A. Smith, Philip M. Brown, Catherine Fox, & P.H. Sönksen. (1978). Pupillary signs in diabetic autonomic neuropathy.. BMJ. 2(6142). 924–927. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact